UB Paderborn / Katalog / Suche / in CDI

4CPS-151 Acetylsalicylic acid desensitisation in patients with coronary artery syndrome: literature review, retrospective analysis and patient follow-up procedure in an iIalian cardiological centre

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A72-A73

2023

Link zum Volltext

Verfügbarkeit prüfen

4CPS-390 Dispensing of anticancer investigational drugs during lockdown for the SARS-CoV-2 pandemic: experience in an oncological centre

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A108-A108

2021

Link zum Volltext

Verfügbarkeit prüfen

Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker

Toxicology letters, 2019-11, Vol.316, p.20-26

2019

Link zum Volltext

Verfügbarkeit prüfen

Management of breast cancer patients during the peak of the COVID 19 pandemic

European journal of surgical oncology, 2021-10, Vol.47 (10), p.2694-2695

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-008 Resistance to sodium heparin treatment or treatment failure to the equivalent analogue?

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A153-A153

2020

Link zum Volltext

Verfügbarkeit prüfen

1ISG-012 The role of the pharmacist in choosing the central venous access device for the prevention of complications: an example of budget impact analysis

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A5-A6

2018

Link zum Volltext

Verfügbarkeit prüfen

4CPS-193 Measuring the impact of hospital pharmacist prescription reviewing in an oncology setting on the pharmacovigilance reporting in a comprehensive cancer centre

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A139-A139

2020

Link zum Volltext

Verfügbarkeit prüfen

4CPS-194 The underreporting rate as a pharmacovigilance process indicator in a comprehensive cancer centre

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A139-A139

2020

Link zum Volltext

Verfügbarkeit prüfen

CP-041 New oral anticoagulants in non-valvular atrial fibrillation patients who are candidates for elective cardioversion: an example of budget impact analysis

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A18-A18

2017

Link zum Volltext

Verfügbarkeit prüfen

4CPS-233 Coverage of energy and protein needs in patients with kidney failure or liver failure receiving total parenteral nutrition

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A149-A150

2018

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-049 Palbociclib in metastatic breast cancer treatment: real life toxicity and frequency of dose reduction or permanent discontinuation

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A172-A172

2020

Link zum Volltext

Verfügbarkeit prüfen

3PC-044 In use physicochemical stability of pembrolizumab under the dilution condition required for use in a day hospital

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A42-A42

2020

Link zum Volltext

Verfügbarkeit prüfen

CP-082 Impact of pharmacists’ expertise on personalised parenteral nutrition prescriptions in an intensive care unit: physicians’ perceptions

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A36-A37

2017

Link zum Volltext

Verfügbarkeit prüfen

GM-021 Zoledronic acid versus denosumab: a budget impact analysis

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A167-A167

2017

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-117 Failure mode and effects criticality analysis: multicentric application on cancer chemotherapy process

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A218-A219

2018

Link zum Volltext

Verfügbarkeit prüfen

4CPS-231 The use of cannabis oil in oncological pain: analysis of the outcomes in real practice at a cancer centre

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A149-A149

2018

Link zum Volltext

Verfügbarkeit prüfen

GM-019 Analysis of the categories of clinical trials in an oncological institute: glimpse into the future

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A166-A166

2017

Link zum Volltext

Verfügbarkeit prüfen

Testing of microbial contamination during the preparation of the radiocompound [⁹⁰Y]DOTATOC for clinical trials: a process validation study by Media Fill approach

The quarterly journal of nuclear medicine and molecular imaging, 2010-10, Vol.54 (5), p.553

2010

Link zum Volltext

Verfügbarkeit prüfen

PCN52 New Insights from CAR-T: An Economic and Organizational Perspective

Value in health, 2020-12, Vol.23, p.S430-S430

2020

Link zum Volltext

Verfügbarkeit prüfen

95P Italian national policy to access molecular tumor boards: Opportunity or restraint for precision oncology?

ESMO open, 2024-02, Vol.9, p.102321, Article 102321

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact of setting of care on pain management in patients with cancer: a multicentre cross-sectional study

Annals of oncology, 2010-10, Vol.21 (10), p.2088-2093

2010

Link zum Volltext

Verfügbarkeit prüfen

Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses administering antineoplastic drugs

Mutation research, 2007-03, Vol.628 (1), p.11-18

2007

Link zum Volltext

Verfügbarkeit prüfen

Is pain reporting to health care professionals age-related? A cross sectional multicenter study in a hospital setting

Expert opinion on pharmacotherapy, 2013-10, Vol.14 (15), p.2011-2017

2013

Link zum Volltext

Verfügbarkeit prüfen

Assay of urinary α-fluoro-β-alanine by gas chromatography-mass spectrometry for the biological monitoring of occupational exposure to 5-fluorouracil in oncology nurses and pharmacy technicians

Biomedical chromatography, 2006-03, Vol.20 (3), p.257-266

2006

Link zum Volltext

Verfügbarkeit prüfen

The ECAD_O project: clinical caring epidemiology of pain in the hospital: the nurses' contribution

Assistenza infermieristica e ricerca, 2009-04, Vol.28 (2), p.73

2009

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

4CPS-151 Acetylsalicylic acid desensitisation in patients with coronary artery syndrome: literature review, retrospective analysis and patient follow-up procedure in an iIalian cardiological centre

4CPS-390 Dispensing of anticancer investigational drugs during lockdown for the SARS-CoV-2 pandemic: experience in an oncological centre

Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker

Management of breast cancer patients during the peak of the COVID 19 pandemic

5PSQ-008 Resistance to sodium heparin treatment or treatment failure to the equivalent analogue?

1ISG-012 The role of the pharmacist in choosing the central venous access device for the prevention of complications: an example of budget impact analysis

4CPS-193 Measuring the impact of hospital pharmacist prescription reviewing in an oncology setting on the pharmacovigilance reporting in a comprehensive cancer centre

4CPS-194 The underreporting rate as a pharmacovigilance process indicator in a comprehensive cancer centre

CP-041 New oral anticoagulants in non-valvular atrial fibrillation patients who are candidates for elective cardioversion: an example of budget impact analysis

4CPS-233 Coverage of energy and protein needs in patients with kidney failure or liver failure receiving total parenteral nutrition

5PSQ-049 Palbociclib in metastatic breast cancer treatment: real life toxicity and frequency of dose reduction or permanent discontinuation

3PC-044 In use physicochemical stability of pembrolizumab under the dilution condition required for use in a day hospital

CP-082 Impact of pharmacists’ expertise on personalised parenteral nutrition prescriptions in an intensive care unit: physicians’ perceptions

GM-021 Zoledronic acid versus denosumab: a budget impact analysis

5PSQ-117 Failure mode and effects criticality analysis: multicentric application on cancer chemotherapy process

4CPS-231 The use of cannabis oil in oncological pain: analysis of the outcomes in real practice at a cancer centre

GM-019 Analysis of the categories of clinical trials in an oncological institute: glimpse into the future

Testing of microbial contamination during the preparation of the radiocompound [⁹⁰Y]DOTATOC for clinical trials: a process validation study by Media Fill approach

PCN52 New Insights from CAR-T: An Economic and Organizational Perspective

95P Italian national policy to access molecular tumor boards: Opportunity or restraint for precision oncology?

Impact of setting of care on pain management in patients with cancer: a multicentre cross-sectional study

Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses administering antineoplastic drugs

Is pain reporting to health care professionals age-related? A cross sectional multicenter study in a hospital setting

Assay of urinary α-fluoro-β-alanine by gas chromatography-mass spectrometry for the biological monitoring of occupational exposure to 5-fluorouracil in oncology nurses and pharmacy technicians

The ECAD_O project: clinical caring epidemiology of pain in the hospital: the nurses' contribution

Suchergebnisse filtern